Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Antibodies in Medicine
Prerna Sharma, Rahul V. Joshi, Robert C. Pritchard, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6438-6438
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Recent Advances in the Development of Monoclonal Antibodies and Next-Generation Antibodies
Rohit Singh, Pankaj Chandley, Soma Rohatgi
ImmunoHorizons (2023) Vol. 7, Iss. 12, pp. 886-897
Open Access | Times Cited: 28
Recent Advances in Micro- and Nano-Drug Delivery Systems Based on Natural and Synthetic Biomaterials
Md. Harun-Or-Rashid, Most. Nazmin Aktar, Md. Sabbir Hossain, et al.
Polymers (2023) Vol. 15, Iss. 23, pp. 4563-4563
Open Access | Times Cited: 27
THPdb2: compilation of FDA approved therapeutic peptides and proteins
Shipra Jain, Srijanee Gupta, Sumeet Patiyal, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104047-104047
Closed Access | Times Cited: 8
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Controlling tangential flow filtration in biomanufacturing processes via machine learning: A literature review
Bastian Oetomo, Ling Luo, Yun Qu, et al.
Digital Chemical Engineering (2025), pp. 100211-100211
Open Access
Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
Masaud Shah, Muhammad Hussain, Hyun Goo Woo
Genomics & Informatics (2025) Vol. 23, Iss. 1
Open Access
Advances in nanobody multimerization and multispecificity: from in vivo assembly to in vitro production
Mohammed Al‐Seragi, Yilun Chen, Franck Duong
Biochemical Society Transactions (2025) Vol. 53, Iss. 01
Open Access
Peptide-Based Regulation of TNF-α-Mediated Cytotoxicity
Betül Zehra Temur, Ahmet Can Timuçin, A. Emin Atik, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 559-559
Open Access
Exploring imaged capillary isoelectric focusing parameters for enhanced charge variants quality control
Virginia Ghizzani, Alessandro Ascione, F. Gonnella, et al.
Frontiers in Chemistry (2025) Vol. 13
Open Access
Next-Generation Therapeutic Antibodies for Cancer Treatment: Advancements, Applications, and Challenges
A. Raja, Abhishek Kasana, Vaishali Verma
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
Towards a structural and functional analysis of the immunoglobulin-fold proteome
Caesar Tawfeeq, James Song, Umesh Khaniya, et al.
Advances in protein chemistry and structural biology (2024), pp. 135-178
Closed Access | Times Cited: 2
Entry of nanoparticles into cells and tissues: status and challenges
Kirsten Sandvig, Tore‐Geir Iversen, Tore Skotland
Beilstein Journal of Nanotechnology (2024) Vol. 15, pp. 1017-1029
Open Access | Times Cited: 2
An update on the novel methods for the discovery of antiseizure and antiepileptogenic medications: where are we in 2024?
Alan Talevi, Carolina L. Bellera
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 8, pp. 975-990
Closed Access | Times Cited: 1
Characterization of Monoclonal Antibody Charge Variants under Near-Native Separation Conditions using Nanoflow Sheath Liquid Capillary Electrophoresis-Mass Spectrometry
Annika A. M. van der Zon, Alisa Höchsmann, Tijmen S. Bos, et al.
(2024)
Open Access | Times Cited: 1
Monoclonal antibodies: From magic bullet to precision weapon
Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1
The future of genetic medicines delivered via targeted lipid nanoparticles to leukocytes
Dana Tarab‐Ravski, Lior Stotsky‐Oterin, Aviad Elisha, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 286-302
Closed Access | Times Cited: 1
Nanobodies: from high-throughput identification to therapeutic development
Peter C. Fridy, Michael P. Rout, Natalia E. Ketaren
Molecular & Cellular Proteomics (2024), pp. 100865-100865
Open Access | Times Cited: 1
Exploring the Biological Activity of a Humanized Anti-CD99 ScFv and Antibody for Targeting T Cell Malignancies
Nuchjira Takheaw, Thanathat Pamonsupornwichit, Ratthakorn Chaiwut, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1422-1422
Open Access | Times Cited: 1
A cell-free workflow for detecting and characterizing RiPP recognition element-precursor peptide interactions
Derek A. Wong, Zachary M. Shaver, Maria D. Cabezas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Biotechnology Advances in Disease Treatment
Sooram Banesh, Surajbhan Sevda
Elsevier eBooks (2024), pp. 511-527
Closed Access
A general approach to reduce off-target radioactivity in vivo via Tetrazine-Knock-Out (TKO)
Swarbhanu Sarkar, Jonathan Pham, Kimberly J. Edwards, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Inter-Antibody Variability in the Clinical Pharmacokinetics of Monoclonal Antibodies Characterized Using Population Physiologically Based Pharmacokinetic Modeling
Mokshada Kumar, Sravani Lanke, Alka Yadav, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 54-54
Open Access
Network-Pharmacology and Central Nervous System Drug Development
Alan Talevi
AAPS introductions in the pharmaceutical sciences (2024), pp. 213-227
Closed Access
Ultrahigh-throughput discovery of modified aptamers as specific and potent enzyme inhibitors
Claire Husser, Janis Hoetzel, Roger Cubì, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The power lies in the glycans
Luca Unione, Jesús Jiménez‐Barbero
eLife (2024) Vol. 13
Open Access
Page 1 - Next Page

Scroll to top